About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Myd88+
wild type
MGI:2436005
Summary 6 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
ht1
Myd88M4Btlr/Myd88+ C57BL/6J-Myd88M4Btlr MGI:6113643
ht2
Myd88poc/Myd88+ C57BL/6-Myd88poc MGI:3641256
cn3
Ighg1tm1(cre)Cgn/Ighg1+
Myd88em1.1Rsky/Myd88+
involves: 129P2/OlaHsd * C57BL/6NTac MGI:7281484
cn4
Cd19tm1(cre/ERT2)Rsky/Cd19+
Myd88em1.1Rsky/Myd88+
involves: 129P2/OlaHsd * C57BL/6NTac MGI:7281485
cn5
Cd19tm1(cre)Cgn/Cd19+
Myd88em1.1Rsky/Myd88+
involves: C57BL/6NTac MGI:7281482
cx6
Ifnar1tm1Agt/Ifnar1tm1Agt
Myd88tm1Aki/Myd88+
B6.129-Myd88tm1Aki Ifnar1tm1Agt MGI:5432885


Genotype
MGI:6113643
ht1
Allelic
Composition
Myd88M4Btlr/Myd88+
Genetic
Background
C57BL/6J-Myd88M4Btlr
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Myd88M4Btlr mutation (0 available); any Myd88 mutation (51 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• reduced TNF secretion in response to the TLR9 ligand CpG oligodeoxynucleotides (CpG ODN) primed with IFN and the TLR7 ligand R848




Genotype
MGI:3641256
ht2
Allelic
Composition
Myd88poc/Myd88+
Genetic
Background
C57BL/6-Myd88poc
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Myd88poc mutation (1 available); any Myd88 mutation (51 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• immunoblot analysis of lysates of heterozygous mutant mouse embryonic fibroblasts (MEFs) using antibody to IkappaB demonstrates normal degradation by these cells of IkappaB in response to interleukin 1 (IL-1)




Genotype
MGI:7281484
cn3
Allelic
Composition
Ighg1tm1(cre)Cgn/Ighg1+
Myd88em1.1Rsky/Myd88+
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6NTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ighg1tm1(cre)Cgn mutation (4 available); any Ighg1 mutation (30 available)
Myd88em1.1Rsky mutation (0 available); any Myd88 mutation (51 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
N
• normal Ig class switching in germinal center B cells after immunization with hapten-carrier conjugate NP-CGG
• normal rise and fall of hapten-specific IgG levels after immunization with hapten-carrier conjugate NP-CGG
• increased frequency in IgM+ plasma cells
• increased frequency and number
• persistently high number of hapten-specific IgM+ plasma cells in spleen and bone marrow for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
• high total plasma cell numbers in spleen and bone marrow for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
• increased frequency and number of plasma cells and germinal center B cells
• high total IgM serum levels for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
• persistently high hapten-specific IgM levels for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG

immune system
• increased frequency in IgM+ plasma cells
• increased frequency and number
• persistently high number of hapten-specific IgM+ plasma cells in spleen and bone marrow for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
• high total plasma cell numbers in spleen and bone marrow for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
• increased frequency and number of plasma cells and germinal center B cells
• high total IgM serum levels for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
• persistently high hapten-specific IgM levels for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
monoclonal gammopathy of uncertain significance DOID:7442 J:308792




Genotype
MGI:7281485
cn4
Allelic
Composition
Cd19tm1(cre/ERT2)Rsky/Cd19+
Myd88em1.1Rsky/Myd88+
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6NTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd19tm1(cre/ERT2)Rsky mutation (1 available); any Cd19 mutation (57 available)
Myd88em1.1Rsky mutation (0 available); any Myd88 mutation (51 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• 15x increase in spleen 10 days after tamoxifen tre
• persistently high number of IgM+ plasma cells in spleen and bone marrow for at least 70 weeks after tamoxifen treatment
• high total IgM serum levels for at least 70 weeks after tamoxifen treatment, displaying discrete paraprotein bands in the gamma-globulin zone upon serum protein electrophoresis

immune system
• 15x increase in spleen 10 days after tamoxifen tre
• persistently high number of IgM+ plasma cells in spleen and bone marrow for at least 70 weeks after tamoxifen treatment
• high total IgM serum levels for at least 70 weeks after tamoxifen treatment, displaying discrete paraprotein bands in the gamma-globulin zone upon serum protein electrophoresis

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
monoclonal gammopathy of uncertain significance DOID:7442 J:308792




Genotype
MGI:7281482
cn5
Allelic
Composition
Cd19tm1(cre)Cgn/Cd19+
Myd88em1.1Rsky/Myd88+
Genetic
Background
involves: C57BL/6NTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd19tm1(cre)Cgn mutation (12 available); any Cd19 mutation (57 available)
Myd88em1.1Rsky mutation (0 available); any Myd88 mutation (51 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
N
• normal B cell development in bone marrow
• normal Ig class switching in B cells in spleen, mesenteric lymph nodes and Peyers patches
• from age 30 weeks
• increased frequency and number from age 30 weeks, increasing over time
• increased number of IgM+ plasma cells
• increased plasma cell compartment in spleen and bone marrow
• increased frequency and number of TACI+ CD138+ plasma cells from age 50 weeks
• increased frequency and number of germinal center B cells from age 30 weeks, increasing over time
• normal frequency of follicular and marginal zone B cells
• increased serum levels from age 10 weeks, increasing over time

immune system
• from age 30 weeks
• increased frequency and number from age 30 weeks, increasing over time
• increased number of IgM+ plasma cells
• increased plasma cell compartment in spleen and bone marrow
• increased frequency and number of TACI+ CD138+ plasma cells from age 50 weeks
• increased frequency and number of germinal center B cells from age 30 weeks, increasing over time
• normal frequency of follicular and marginal zone B cells
• increased serum levels from age 10 weeks, increasing over time

growth/size/body
• from age 30 weeks




Genotype
MGI:5432885
cx6
Allelic
Composition
Ifnar1tm1Agt/Ifnar1tm1Agt
Myd88tm1Aki/Myd88+
Genetic
Background
B6.129-Myd88tm1Aki Ifnar1tm1Agt
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ifnar1tm1Agt mutation (13 available); any Ifnar1 mutation (62 available)
Myd88tm1Aki mutation (9 available); any Myd88 mutation (51 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• in cultured bone marrow dendritic cells from mice infected with Trypanosoma cruzi the number of trypomastigotes released into the supernatant is slightly increased and the replication within macrophages is slightly enhanced compared to controls
• slight increase in the number of trypomastigotes in the serum of T. cruzi infected mice





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
01/06/2026
MGI 6.24
The Jackson Laboratory